Papers associated with hindbrain (and tert)

Limit to papers also referencing gene:
Show all hindbrain papers

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest

Sort Oldest To Newest

	Similarity in gene-regulatory networks suggests that cancer cells share characteristics of embryonic neural cells., Zhang Z., J Biol Chem. August 4, 2017; 292 (31): 12842-12859.
	Transdifferentiation from cornea to lens in Xenopus laevis depends on BMP signalling and involves upregulation of Wnt signalling., Day RC., BMC Dev Biol. January 26, 2011; 11 54.
	Purified E255L mutant SERCA1a and purified PfATP6 are sensitive to SERCA-type inhibitors but insensitive to artemisinins., Cardi D., J Biol Chem. August 20, 2010; 285 (34): 26406-16.
	The glutamate receptor GluR5 agonist (S)-2-amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid and the 8-methyl analogue: synthesis, molecular pharmacology, and biostructural characterization., Clausen RP., J Med Chem. August 13, 2009; 52 (15): 4911-22.
	Tetrazolyl isoxazole amino acids as ionotropic glutamate receptor antagonists: synthesis, modelling and molecular pharmacology., Frølund B., Bioorg Med Chem. September 15, 2005; 13 (18): 5391-8.
	Structural determinants of agonist-specific kinetics at the ionotropic glutamate receptor 2., Holm MM., Proc Natl Acad Sci U S A. August 23, 2005; 102 (34): 12053-8.
	(S)-2-Amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid, a potent and selective agonist at the GluR5 subtype of ionotropic glutamate receptors. Synthesis, modeling, and molecular pharmacology., Brehm L., J Med Chem. April 10, 2003; 46 (8): 1350-8.
	Stereochemistry and molecular pharmacology of (S)-thio-ATPA, a new potent and selective GluR5 agonist., Stensbøl TB., Eur J Pharmacol. January 12, 2001; 411 (3): 245-53.
	Resolution, absolute stereochemistry and molecular pharmacology of the enantiomers of ATPA., Stensbøl TB., Eur J Pharmacol. September 10, 1999; 380 (2-3): 153-62.
	Resolution, absolute stereochemistry, and enantiopharmacology of the GluR1-4 and GluR5 antagonist 2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid., Møller EH., Chirality. January 1, 1999; 11 (10): 752-9.
	Antagonist properties of a phosphono isoxazole amino acid at glutamate R1-4 (R,S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid receptor subtypes., Wahl P., Mol Pharmacol. March 1, 1998; 53 (3): 590-6.
	Pharmacology and toxicology of ATOA, an AMPA receptor antagonist and a partial agonist at GluR5 receptors., Wahl P., Neuropharmacology. January 1, 1998; 37 (10-11): 1205-10.

???pagination.result.page??? 1